Clinical trial · Interventional
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Pelvic and Aortic-cava Lymphadenectomy Randomized Phase III for Advanced Ovarian Cancer
NCT01218490CI-TRIAL-00038676CARACOsuspendedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): qualitative analysis of the study database
Summary
Brief summary (as posted)
It is a multicenter randomized trial of superior cleaning compared the absence of dissection in stage III patients with optimal surgical resection without retroperitoneal lymph node palpable.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ovarian cancer surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- lymphadenectomy
- description
- after surgery of the ovarian cancer, patient will have Pelvis and aortic-cava lymphadenectomy
- interventionNames
- Procedure: ovarian cancer surgery
- type
- NO_INTERVENTION
- label
- no lymphadectomy
- description
- after surgery, the patient will not have pelvic and aortic-cave lymphadenectomy
Primary outcomes (1)
- measure
- survival with out recurrence
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age\> 18 years * Karnofsky\> 80, or ASA I-II * Primary ovarian adenocarcinoma, or primitive peritoneal * No retroperitoneal lymph node\> 2cm (CT; MRI) * Complete surgical staging * Stage III-IV FIGO classification * Indication of systemic chemotherapy before surgery or post surgery Exclusion Criteria: * Non Invasive Cancer * non-epithelial or borderline cancer * Pregnancy * Previous pelvic lymphadenectomy or aortic-cava for a disease other than ovarian cancer * Contraindication to Platinum and Paclitaxel * Borderline Ovarian Tumor * tumor recurrence * Incomplete surgery, resectable lesion, Surgery sub optimal (R\> 1cm)
References
Publications (0)
Data not yet available
No reference posted for this study.